Landing Page text for Doctors in row.png
Landing Page Text-01.png
Landing Page Text-01.png
Plasma-derived Medicinal Products (PDMP’s) Update:

WPBTS suspends the manufacture of its PDMP’s until further notice, due to critical findings in the recent audit review of the WPBTS Fractionation Plant.

Pathogen Reduction Evaluation:

WPBTS and SANBS are evaluating/reviewing the feasibility of pathogen reduction technology for pooled random donor platelets and single donor apheresis platelets for implementation in South Africa.

Haemovigilance Report:

WPBTS and SANBS’s reporting of adverse blood transfusion/donation events in South Africa is available in the latest SA National Haemovigilance Report (2014), on the haemovigilance information page. 

Customer Satisfaction Survey:

WPBTS is conducting its annual customer satisfaction survey for blood users. To participate in the survey visit the Life Blood Newsletter Edition 26, on the latest news page.  

The heart of transfusion medicine

The clinical guidelines for the use of blood products in South Africa is jointly published by the blood services in South Africa. Its aim is to provide clinicians with useful information about blood products and brief guidelines for their optimum use.

Patient Blood Management (PBM) is an evidence-based, multidisciplinary approach to optimising the care of patients who might need transfusions and has become an important part of transfusion medicine. This 5th Edition of the Clinical Guidelines for the use of Blood Products in South Africa has taken into account the evidence-based guidelines that were released by AABB in 2010 and 2012, respectively. As noted in the foreword to the 4th Edition, blood transfusion is the cornerstone of therapy for many serious and common diseases. Without the ready availability of blood components it would be difficult to implement modern treatment regimens for many malignant diseases and complex surgical procedures.

View Clinical Guidelines for the Use of Blood Products in South Africa, 5th Edition.
Download Clinical Guidelines for the Use of Blood Products in South Africa, 5th Edition.(2.42MB)